- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01770002
Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved?
April 15, 2015 updated by: University of California, Davis
The investigators hypothesize that everting wound edges while suturing surgical sites will result in more aesthetic scars.
Additionally, we also hypothesize that small to moderate wound irregularities present at 3 months will resolve by 6 months after surgery with no intervention
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Sacramento, California, United States, 95816
- UC Davis, Department of Dermatology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Over 18 years of age
- Able to give informed consent themselves
- Willing to return for follow up visits
Exclusion Criteria:
- Mentally handicapped
- Unable to understand written and oral English
- Incarceration
- Under 18 years of age
- Unwilling to return for follow up
- Pregnant Women
- Wounds less than 3 cm in length
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Everted suture technique
Technique that everts the skin; the edges will sit up against each other in a little peak, raised above the surrounding skin.
|
|
|
ACTIVE_COMPARATOR: Non-everted suture technique
Surgical wound will be approximated such that the suture line is flat relative to the surrounding skin.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Everted versus non-everted suturing techniques
Time Frame: 3 and 6 months
|
Primary outcome measures for this study are the post operative scar width measured at 1 cm from the midline on both sides of the scar.
|
3 and 6 months
|
|
Mean score of sum of 2 blinded observers POSAS scores
Time Frame: 3 and 6 months
|
The mean summed total of two blinded reviewers Physician Observer Scar Assessment Scale (POSAS) scores for each side of the wound.
|
3 and 6 months
|
|
Scar measurements (height, width, length)
Time Frame: 3 and 6 months
|
Scar volume will be measured in centimeters on both sides of the wound
|
3 and 6 months
|
|
Scar induration
Time Frame: 3 and 6 months
|
Scar induration area will be measured in centimeters for both sides of the wound
|
3 and 6 months
|
|
Scar erythema
Time Frame: 3 and 6 months
|
Scar erythema area will be measured in centimeters for both sides of the wound
|
3 and 6 months
|
|
Wound contour irregularities
Time Frame: 3 and 6 months
|
Wound contour irregularities will be measured in terms of volume in cubic centimeters via a length, width and height measurement
|
3 and 6 months
|
|
Stand cone volume
Time Frame: 3 and 6 months
|
The volume of standing cones will be measured via length, width and height measurements in centimeters
|
3 and 6 months
|
|
Uneven edge measurement
Time Frame: 3 and 6 months
|
The area of uneven edges will be measured via a length x height measurement in centimeters
|
3 and 6 months
|
|
Hyperpigmentation area
Time Frame: 3 and 6 months
|
areas of hyperpigmentation will be measured via a length x width measurement in centimeters
|
3 and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Infection
Time Frame: up to 6 months
|
Infections occurring anytime during the study period will be recorded
|
up to 6 months
|
|
wound dehiscence
Time Frame: up to 6 months
|
incidence of wound infection will be recorded anytime during the study period
|
up to 6 months
|
|
spitting sutures
Time Frame: 3 and 6 months
|
spitting sutures will be counted for each side of the wound at 3 and 6 months
|
3 and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (ACTUAL)
September 1, 2013
Study Completion (ACTUAL)
September 1, 2014
Study Registration Dates
First Submitted
January 15, 2013
First Submitted That Met QC Criteria
January 15, 2013
First Posted (ESTIMATE)
January 17, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
April 16, 2015
Last Update Submitted That Met QC Criteria
April 15, 2015
Last Verified
April 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 265161
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.